Literature DB >> 3555783

The epidemiology and endocrinology of the menarche in relation to breast cancer.

R K Vihko, D L Apter.   

Abstract

The search for major endocrine abnormalities as causes for breast cancer has not been successful, whether it has been directed to patients with this disease, or to different groups or populations at risk, such as women who have had an early menarche. There were, however, clear-cut differences in a number of variables when the pubertal development of girls with an early menarche was compared with that in other girls. The girls with an early menarche, compared to those with a late menarche, had an early increase in serum concentrations of follicle stimulating hormone, higher circulating oestradiol concentrations before and for several years after menarche and lower serum sex hormone-binding globulin concentrations for several years after menarche, the last two leading to higher 'free oestradiol indices' in the serum. Early menarche was characterized by early onset of ovulatory cycles. We found that the times from menarche until 50% of the cycles were ovulatory were about 1, 3 and 4.5 years, when the ages at menarche were less than 12, 12-12.9 and more than or equal to 13 years, respectively. In addition, the luteal phase of the menstrual cycles of subjects with an early menarche was adequate more frequently than that of subjects with a later menarche. These findings are compatible with the view that girls with an early menarche have a more profound decrease in the sensitivity of the hypothalamic-pituitary axis to the negative feedback of circulating steroids. The associations between endocrine variables and body weight and percentage of fat seem to be primarily determined by the endocrine variables. Altogether the data on early menarche suggest that early-onset regular cyclic ovarian function is related to the increased risk of breast cancer that is associated with this category of women. Athletic activities may delay menarche, which may have relevance for reducing the risk of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3555783

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  8 in total

1.  Potential applications of salivary steroid immunoassays for investigations of cancer of reproductive tissues.

Authors:  P F Fottrell
Journal:  Br J Cancer Suppl       Date:  1988-12

2.  Age at menarche as a fitness trait: nonadditive genetic variance detected in a large twin sample.

Authors:  S A Treloar; N G Martin
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

3.  Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies.

Authors:  Chunyan He; Cuilin Zhang; David J Hunter; Susan E Hankinson; Germaine M Buck Louis; Mary L Hediger; Frank B Hu
Journal:  Am J Epidemiol       Date:  2009-12-21       Impact factor: 4.897

4.  Maternal age of menarche is not associated with asthma or atopy in prepubertal children.

Authors:  A Maitra; A Sherriff; K Northstone; D Strachan; A J Henderson
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

5.  Quality of early family relationships and individual differences in the timing of pubertal maturation in girls: a longitudinal test of an evolutionary model.

Authors:  B J Ellis; S McFadyen-Ketchum; K A Dodge; G S Pettit; J E Bates
Journal:  J Pers Soc Psychol       Date:  1999-08

Review 6.  Associations between physical activity and susceptibility to cancer: possible mechanisms.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1998-11       Impact factor: 11.136

7.  Blood concentrations of estradiol and sex hormone-binding globulin in relation to age at menarche in premenopausal British and Japanese women.

Authors:  J W Moore; T J Key; D Y Wang; R D Bulbrook; J L Hayward; O Takatani
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

8.  The association between age at menarche and chronic pain outcomes in women: the Tromsø Study, 2007 to 2016.

Authors:  Charlotte I Lund; Bo Engdahl; Leiv A Rosseland; Audun Stubhaug; Guri Grimnes; Anne-Sofie Furberg; Ólöf A Steingrímsdóttir; Christopher S Nielsen
Journal:  Pain       Date:  2022-03-01       Impact factor: 7.926

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.